Phototoxic action of meloxicam contributes to dysregulation of redox homeostasis in normal human skin cells - Molecular and biochemical analysis of antioxidant enzymes in melanocytes and fibroblasts.

Catalase Fibroblasts Glutathione peroxidase Melanocytes Meloxicam Superoxide dismutase

Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 20 07 2023
revised: 08 11 2023
accepted: 24 11 2023
pubmed: 1 12 2023
medline: 1 12 2023
entrez: 30 11 2023
Statut: aheadofprint

Résumé

The phototoxic effect of meloxicam (MLX) raises the question of the effect of the drug on the redox homeostasis of normal human skin cells. The main objective of the study was to analyze the effect of MLX and/or UVA radiation (UVAR) on the redox homeostasis of human normal skin cells - melanocytes and fibroblasts. MLX was found to affect the activity and expression of enzymes of the antioxidant system differently depending on the cell line used. The drug decreased the activity and expression of superoxide dismutase type 1 and 2 (SOD1 and SOD2), catalase (CAT) and glutathione peroxidase (GPx) in fibroblasts, while increasing the activity of these enzymes in melanocytes. UVA radiation enhanced the effects of the drug. In conclusion, MLX in combination with UVAR induces oxidative stress in melanocytes and fibroblasts, however, the analyses showed that the drug's effect the activity and expression of SOD, CAT and GPx differently, depending on the cell line. The observed dissimilarity between tested cell lines may result from the presence of melanin pigments.

Identifiants

pubmed: 38036073
pii: S0887-2333(23)00194-7
doi: 10.1016/j.tiv.2023.105745
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105745

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors M.K., J.R., J.K., Z.R., K.B., and D.W. declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Auteurs

Marta Karkoszka (M)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska4, 41-200 Sosnowiec, Poland. Electronic address: d200971@365.sum.edu.pl.

Jakub Rok (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska4, 41-200 Sosnowiec, Poland. Electronic address: jrok@sum.edu.pl.

Justyna Kowalska (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska4, 41-200 Sosnowiec, Poland. Electronic address: jkowalska@sum.edu.pl.

Zuzanna Rzepka (Z)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska4, 41-200 Sosnowiec, Poland. Electronic address: zrzepka@sum.edu.pl.

Klaudia Banach (K)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska4, 41-200 Sosnowiec, Poland. Electronic address: kbanach@sum.edu.pl.

Dorota Wrześniok (D)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska4, 41-200 Sosnowiec, Poland. Electronic address: dwrzesniok@sum.edu.pl.

Classifications MeSH